Risk of GERD-Related Disorders in Obese Patients on PPI Therapy: a Population Analysis

ConclusionsIn obese patients on PPI therapy for reflux, higher BMIs were not associated with increased risk of BE or esophageal carcinoma. Males, older patients, and those with hiatus hernias are at increased risk of developing BE and carcinoma. Failure of PPI monotherapy is predictive of future metaplasia and dysplasia.
Source: Obesity Surgery - Category: Surgery Source Type: research